Controlled release implants for cardiovascular disease

This publication has 30 references indexed in Scilit:

• Controlled release of 1-hydroxyethylidene diphosphonate: in vitro assessment and effects on bioprosthetic calcification in sheep tricuspid valve replacements
  International Journal of Pharmaceutics, 1989
• Cardiac controlled release for arrhythmia therapy: Lidocaine-polyurethane matrix studies
  Journal of Controlled Release, 1988
• Accentuated antagonism between beta-adrenergic and vagal effects on ventricular refractoriness in humans.
  Circulation, 1988
• Development of congestive heart failure and alterations in left ventricular function in patients with sustained ventricular tachyarrhythmias treated with amiodarone
  The American Journal of Cardiology, 1987
• Controlled-Release Drug Delivery of Diphosphonates to Inhibit Bioprosthetic Heart Valve Calcification: Release Rate Modulation with Silicone Matrices Via Drug Solubility and Membrane Coating
  Journal of Pharmaceutical Sciences, 1987
• Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: Dose-response and mechanistic studies
  Journal of Controlled Release, 1986
• Lidocaine's negative inotropic and antiarrhythmic actions. Dependence on shortening of action potential duration and reduction of intracellular sodium activity.
  Circulation Research, 1985
• Inhibition of Calcification of Bioprosthetic Heart Valves by Local Controlled-Release Diphosphonate
  Science, 1985
• [32] Poly(lactic/glycolic acid) biodegradable drug—polymer matrix systems
  Published by Elsevier ,1985
• Polymers for the sustained release of proteins and other macromolecules
  Nature, 1976